SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007706
Filing Date
2016-08-09
Accepted
2016-08-09 06:07:27
Documents
94
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20160630x10q.htm 10-Q 2484479
2 EX-10.1 amph-20160630ex101821b31.htm EX-10.1 127920
3 EX-31.1 amph-20160630ex3119559c3.htm EX-31.1 14746
4 EX-31.2 amph-20160630ex312243ebe.htm EX-31.2 14714
5 EX-32.1 amph-20160630ex321905fae.htm EX-32.1 10156
6 EX-32.2 amph-20160630ex32237ebfa.htm EX-32.2 10143
  Complete submission text file 0001558370-16-007706.txt   10966667

Data Files

Seq Description Document Type Size
7 EX-101.INS amph-20160630.xml EX-101.INS 2780447
8 EX-101.SCH amph-20160630.xsd EX-101.SCH 72714
9 EX-101.CAL amph-20160630_cal.xml EX-101.CAL 57860
10 EX-101.DEF amph-20160630_def.xml EX-101.DEF 250780
11 EX-101.LAB amph-20160630_lab.xml EX-101.LAB 502289
12 EX-101.PRE amph-20160630_pre.xml EX-101.PRE 452702
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 161815939
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences